Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Ho-Pun-Cheung

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
International Journal of Cancer|September 9, 2010
EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancerAlexandre Ho-Pun-Cheung, Eric Assenat, Caroline Bascoul-Mollevi, et al.
Cancers|April 3, 2020
<i>BRCA1</i> Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast CancerWilliam Jacot, Evelyne Lopez-Crapez, Caroline Mollevi, et al.
Plos One|July 26, 2012
Quantification of HER expression and dimerization in patients' tumor samples using time-resolved Förster resonance energy transferAlexandre Ho-Pun-Cheung, Hervé Bazin, Nadège Gaborit, et al.
British Journal of Cancer|December 4, 2019
Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samplesAlexandre Ho-Pun-Cheung, Hervé Bazin, Florence Boissière-Michot, et al.
International Journal of Cancer|January 6, 2021
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1)Eric Assenat, Laurent Mineur, Caroline Mollevi, et al.
Clinical Colorectal Cancer|August 2, 2020
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)Emmanuelle Samalin, Christelle de la Fouchardière, Simon Thézenas, et al.
Cancers|September 10, 2021
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III TumorsPascale Palassin, Marion Lapierre, Samuel Pyrdziak, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Cancer|September 9, 2010
EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancerAlexandre Ho-Pun-Cheung, Eric Assenat, Caroline Bascoul-Mollevi, et al.
Cancers|April 3, 2020
<i>BRCA1</i> Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast CancerWilliam Jacot, Evelyne Lopez-Crapez, Caroline Mollevi, et al.
Plos One|July 26, 2012
Quantification of HER expression and dimerization in patients' tumor samples using time-resolved Förster resonance energy transferAlexandre Ho-Pun-Cheung, Hervé Bazin, Nadège Gaborit, et al.
British Journal of Cancer|December 4, 2019
Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samplesAlexandre Ho-Pun-Cheung, Hervé Bazin, Florence Boissière-Michot, et al.
International Journal of Cancer|January 6, 2021
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1)Eric Assenat, Laurent Mineur, Caroline Mollevi, et al.
Clinical Colorectal Cancer|August 2, 2020
Sorafenib Plus Irinotecan Combination in Patients With RAS-mutated Metastatic Colorectal Cancer Refractory To Standard Combined Chemotherapies: A Multicenter, Randomized Phase 2 Trial (NEXIRI-2/PRODIGE 27)Emmanuelle Samalin, Christelle de la Fouchardière, Simon Thézenas, et al.
Cancers|September 10, 2021
A Truncated NRIP1 Mutant Amplifies Microsatellite Instability of Colorectal Cancer by Regulating MSH2/MSH6 Expression, and Is a Prognostic Marker of Stage III TumorsPascale Palassin, Marion Lapierre, Samuel Pyrdziak, et al.
Pageof 2